[ET Net News Agency, 27 March 2026] CHINARES PHARMA (03320) rose 5.6% to HK$5.63.
It hits an intra-day high of HK$5.63, hitting an 1-month high, and an intra-day low of HK$5.23. The total shares traded was 47.75 million, with a value of HK$261.63m. The active buy/sell ratio is 59:41, with net buying turnover of HK$45.73m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$18.31m, with volume weighted average price of HK$5.493. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$55.82m, with volume weighted average price of HK$5.482. The stock has risen a combined 27.1% over the past 4 consecutive trading days.
Basic Information| Nominal | 5.630 | % Chg | +5.63% |
| High | 5.630 | Low | 5.230 |
| Shares Tr | 47.75m | Turnover | 261.63m |
| 10-D SMA | 4.797 | %H.V | 51.144 |
| 20-D SMA | 4.647 | VWAP | 5.479 |
| 50-D SMA | 4.610 | RSI14 | 80.159 |
Status: Hitting an 1-month high, active buy/sell ratio is 59:41, with net buying turnover of HK$45.73m, rising a combined 27.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| CHINARES PHARMA (03320) | 5.63 | +5.63 |
| SIHUAN PHARM (00460) | 1.34 | +4.69 |
| GRAND PHARMA (00512) | 6.75 | +2.58 |
| SINO BIOPHARM (01177) | 5.83 | +0.17 |
| HENGRUI PHARMA (01276) | 65.30 | +6.61 |
| LIVZON PHARMA (01513) | 27.18 | +2.57 |
| LUYE PHARMA (02186) | 2.40 | +3.90 |
| FOSUN PHARMA (02196) | 19.76 | +5.16 |
| SH PHARMA (02607) | 11.45 | +1.96 |
| HANSOH PHARMA (03692) | 32.72 | +5.07 |
(ed)
Nominal 
